4th Circ. Upholds Dismissal Of Inspire Securities Suit
A federal appeals court has affirmed the dismissal of a consolidated class action against Inspire Pharmaceuticals Inc. that accused the company of overstating the likely success of Prolacria, an experimental dry...To view the full article, register now.
Already a subscriber? Click here to view full article